139911-09-4

Basic information

• Product Name: 3,3',5,5'-TETRAFLUOROBENZOPHENONE
• Synonyms: 3,3',5,5'-TETRAFLUOROBENZOPHENONE
• CAS NO: 139911-09-4
• Molecular Formula: C₁₃H₆F₄O
• Molecular Weight: 254.18
• Mol File: 139911-09-4.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 99°C/0.1mm
• Flash Point: 124.6°C
• Appearance: /
• Density: 1.378g/cm³
• Vapor Pressure: 0.000237mmHg at 25°C
• Refractive Index: 1.519
• CAS DataBase Reference: 3,3',5,5'-TETRAFLUOROBENZOPHENONE(CAS DataBase Reference)
• NIST Chemistry Reference: 3,3',5,5'-TETRAFLUOROBENZOPHENONE(139911-09-4)
• EPA Substance Registry System: 3,3',5,5'-TETRAFLUOROBENZOPHENONE(139911-09-4)

Safety Data

• Statements: 36/37/38
• Safety Statements: 26-36/37/39
• Hazardous Substances Data: 139911-09-4(Hazardous Substances Data)

Usage

InChI:InChI=1/C13H6F4O/c14-9-1-7(2-10(15)5-9)13(18)8-3-11(16)6-12(17)4-8/h1-6H

Upstream product

• 461-96-1 3,5-difluorobromobenzene 
• 139911-07-2 3,3',5,5'-tetrafluorobenzhydrol 

Relevant articles and documents

NOVEL BENZODIOXOLES

The present invention relates to compound of formula (I) Wherein R1, R2, R3, R4, R5, R6, R7, and X are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prophylaxis of diseases, which are associated with the modulation of CB1 receptors.

Spiro-tricyclicaromatic succinimide derivatives

Disclosed are substituted or unsubstituted planar tricyclic fluorene or nuclear analogs thereof, spiro-coupled to a five-membered ring containing a secondary amide, and the pharmaceutically acceptable salts thereof. These compounds are useful, inter alia, in the treatment of diabetes. Also disclosed are processes for the preparation of such compounds; pharmaceutical compositions comprising such compounds; and methods of treatment comprising administering such compounds and compositions when indicated for, inter alia, long term, prophylactic treatment of the diabetes syndrome.